China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHA:600062)

China · Delayed Price · Currency is CNY

18.56

+0.15 (0.81%)

Apr 8, 2026, 3:00 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Offset of Business Segment			-120.97M	-92.76M	-94.27M	-89.76M	-113.24M
Infusion			3.31B	2.69B	2.71B	2.59B	3.05B
Infusion Growth			23.20%	-0.76%	4.78%	-15.32%	4.85%
Non-Infusion			8.12B	7.03B	6.50B	6.01B	6.44B
Non-Infusion Growth			15.50%	8.20%	8.13%	-6.72%	19.15%
Total			11.31B	9.63B	9.11B	8.50B	9.38B
Total Growth			17.50%	5.64%	7.14%	-9.35%	14.05%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China			11.31B	9.63B	9.11B	8.50B	9.38B
China Growth			17.50%	5.64%	7.14%	-9.35%	14.05%
Total			11.31B	9.63B	9.11B	8.50B	9.38B
Total Growth			17.50%	5.64%	7.14%	-9.35%	14.05%

Source: S&P Global Market Intelligence.